MISSISSAUGA, ON, July 8, 2025 /CNW/ -- Abbott (NYSE: ABT) today announced that its latest generation of sensor-based glucose monitoring technology, the FreeStyle Libre 3 Plus * sensor, is now ...
Abbott Laboratories ABT presented late-breaking clinical data that demonstrate the FreeStyle Libre 3 system is the most accurate 14-day continuous glucose monitor. The results were presented at the ...
Mary is an associate editor covering technology, culture and everything in between. She recently graduated from the University of North Carolina at Chapel Hill, where she served as an editor at The ...
Monitoring your blood sugar level no longer requires you to draw blood. The U.S. Food and Drug Administration (FDA) has approved a device that will bring diabetes patients into the 21st century of ...
ABBOTT PARK, Ill., Sept. 28, 2020 /PRNewswire/ -- Abbott (NYSE: ABT), the worldwide leader in continuous glucose monitoring (CGM) technology, 8 announced today it has secured CE Mark (Conformité ...
The Freestyle Libre 14 day is now the longest-lasting self-applied continuous glucose sensing technology available and allows the used to wear the sensor for up to 14 days with high accuracy. ABBOTT ...
Use of the novel FreeStyle Libre glucose monitoring system (Abbott) leads to improved glycemic control among people with diabetes, new real-world data indicate. Findings from deidentified data for ...
Glucose monitoring is key to effective diabetes management as it helps people living with diabetes understand how their body responds to food, exercise, and medications 3. It empowers them to take an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback